Page 4 - Formp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wall Street brokerages expect Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) to report sales of $700,000.00 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Oramed Pharmaceuticals’ earnings. Oramed Pharmaceuticals posted sales of $680,000.00 in the same quarter last year, which would indicate a positive year-over-year growth rate of […]

Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Thursday. A number of other research firms have also recently commented on ORMP. Cantor Fitzgerald initiated coverage on Oramed Pharmaceuticals in a research report on Friday, February 18th. They set an “overweight” […]

President's company and its cfo, that trial is expected to go, that trial is expected in court later this i year, at the end o the summer, beginning of the fall. now, we don't know if any additional charges will be brought in that case at all, particularly with the release af this deposition in which trump claimsio full personal responsibility formp the compensationon arrangement of another employee who appears to have been paid in a similar manner to the man who is here in handcuffs. we have suspected over the last few days and today it was reported by cnn that the special grand jurywa conven...

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) has earned an average rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and five have given a buy rating to the company. The average 1 year price target among […]

Equities analysts expect that Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) will report earnings per share of ($0.19) for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Oramed Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.23) and the highest estimate coming in at ($0.15). Oramed Pharmaceuticals posted earnings […]